These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25646021)

  • 1. Implications of United States patent laws on the advancement of vascular surgery.
    Mousa AY; Broce M
    Vascular; 2015 Apr; 23(2):221. PubMed ID: 25646021
    [No Abstract]   [Full Text] [Related]  

  • 2. The application of the patent laws to the drug approval process.
    Coggio BD; Cerrito FD
    Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669
    [No Abstract]   [Full Text] [Related]  

  • 3. The Patent Laws and Patent Office Practice.
    JAMA; 2017 Jun; 317(23):2455. PubMed ID: 28632856
    [No Abstract]   [Full Text] [Related]  

  • 4. Complaint against Argentina over protection of patents and test data.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2000; 5(4):29. PubMed ID: 11833164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 6. Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering.
    Paine CS
    Seton Hall Law Rev; 2003; 33(2):479-510. PubMed ID: 12715807
    [No Abstract]   [Full Text] [Related]  

  • 7. Publish and perish: what constitutes a bar under the patent laws.
    Teitelbaum R; Cohen MS
    Nat Biotechnol; 2004 Nov; 22(11):1449-51. PubMed ID: 15529168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent owner options for correcting errors in US patents after grant.
    Armstrong M
    Pharm Pat Anal; 2014 Sep; 3(5):499-508. PubMed ID: 25374319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene patent policy: does issuing gene patents accord with the purposes of the U.S. patent system?
    Bradshaw J
    Willamette Law Rev; 2001; 37(4):637-60. PubMed ID: 12774776
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical patent settlements: the antitrust risks.
    Balto DA
    Food Drug Law J; 2000; 55(3):321-41. PubMed ID: 11824464
    [No Abstract]   [Full Text] [Related]  

  • 11. The end of DNA patents in the United States?
    Webber P
    Expert Opin Ther Pat; 2013 Dec; 23(12):1525-7. PubMed ID: 24138004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
    Garber K
    Science; 2006 May; 312(5775):827. PubMed ID: 16690824
    [No Abstract]   [Full Text] [Related]  

  • 13. Patent watch: Have the biosimilar floodgates been opened in the United States?
    Brinckerhoff CC; Schorr K
    Nat Rev Drug Discov; 2015 May; 14(5):303-4. PubMed ID: 25924576
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent watch: post-approval testing shielded from patent infringement.
    Harrison C
    Nat Rev Drug Discov; 2012 Sep; 11(9):666. PubMed ID: 23097768
    [No Abstract]   [Full Text] [Related]  

  • 15. Patent infringement. Court denies motion to alter patent claim decision.
    AIDS Policy Law; 2003 Dec; 18(22):6. PubMed ID: 14974399
    [No Abstract]   [Full Text] [Related]  

  • 16. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape.
    Lu DL; Kowalski TJ; Jarecki-Black J
    Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetics. Trends in human gene patent litigation.
    Holman CM
    Science; 2008 Oct; 322(5899):198-9. PubMed ID: 18845733
    [No Abstract]   [Full Text] [Related]  

  • 18. US Patent Office issues guidelines on natural product patent eligibility.
    Harrison C
    Nat Rev Drug Discov; 2014 Apr; 13(4):250. PubMed ID: 24687057
    [No Abstract]   [Full Text] [Related]  

  • 19. Use patents, carve-outs, and incentives--a new battle in the drug-patent wars.
    Rai A
    N Engl J Med; 2012 Aug; 367(6):491-3. PubMed ID: 22873529
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.